Understanding infectious diseases to better control them
The CIRI (Centre International de Recherche en Infectiologie) brings together the scientific and medical research communities in infectious diseases and immunity in the Lyon-St Etienne area, with the University of Lyon 1, Inserm, CNRS and ENS de Lyon as main managing bodies, and Hospices Civils de Lyon and Université Jean Monnet as secondary managing bodies, and important partnerships with VetAgroSup and Institut Pasteur. More than 400 researchers with complementary disciplinary backgrounds are grouped into 3 main departments: immunologists, bacteriologists and virologists, some of them being as well as cancerologists and epidemiologists. They work together with the main objective of understanding the biology of microbes and the immune system, and the interactions between microbes and their hosts, in order to better combat infectious diseases and other illnesses involving the immune system.
- Three departments working together
- Publications
-
Alexandre Legrand, Rémi Demeure, Amandine Chantharath, Carine Rey, Julie Baltenneck, Cameron L. M. Gilchrist, Joana L. Rocha, Clara Loyer, Léa Picard, Andrea Cimarelli, Martin Steinegger, Francois Rousset, Peter H. Sudmant and Lucie Etienne
-
Publications of RSV Study Group Lyon
-
- Lung virome convergence precedes hospital-acquired pneumonia in intubated critically ill patients Anani et al. Cell Rep Medicine - Team VirPath-CARVI
- News
-
Chaque année, l’Institut des sciences biologiques du CNRS et la Fondation CNRS décernent deux prix Claude Paoletti, à de jeunes chercheuses et chercheurs qui ont su se distinguer dès leur doctorat ou post-doctorat pour leurs travaux en sciences de la vie. François Rousset obtient le prix Paoletti 2025 pour ses travaux concernant les interactions entre les bactéries et leurs virus, les phages.
-
Félicitations à Lucie ETIENNE, Directrice de Recherche au Centre International de Recherche en Infectiologie (CNRS/ ENS de Lyon / INSERM / Université Claude Bernard Lyon 1 / Hospices Civils de Lyon / Université Jean Monnet – Saint-Etienne) pour l’obtention d’un ERC Consolidator Grant pour le projet FUNEVO !
-
Publication of the I2BA team in The Journal of Experimental Medicine
-
International Call for the Recruitment of an Early-Career Team Leader in Virology at CIRI.
- Job offers
- The HEAL team is seeking for a PhD candidate to start a research project on the cellular and molecular aspects of “Orthonairovirus: molecular determinants of transmission”
- The VIRPATH laboratory at the International Center for Research in Infectiology (CIRI) is inviting applications from motivated, independent postdoctoral researchers to lead cutting-edge projects foc (...)
- L’équipe dirigée par Olivier Thaunat recrute un·e ingénieur·e en Immunologie dans le cadre d’un projet ANR portant sur les mécanismes d’allo-reconnaissance en transplantation
-
Post-doc offer at the CERP (Center of Excellence in Respiratory Pathogens)
- A PhD under a "CIFRE convention" is opened in EIA team. It will start in September 2024.
-
EVIR Team: "Genetic reprogramming of B cells to enhance their therapeutic properties before autologous transfer"
- Agenda
-
“Host adaptations to viral infections” Meeting at CNRS Station Biologique de Roscoff: Register now!
Peter Sudmant (UC Berkeley, USA), David Enard (Univ. Arizona, USA) and Lucie Etienne (CIRI, CNRS / (...)
-
Réunion annuelle AC42
Réseau National Hépatites de l'ANRS | Maladies Infectieuses Emergentes
-
CFATG10
10èmes Journées Scientifiques de l’Autophagie
-
séminaire CIRI : Pr. Miles W CARROLL (17.12.2025)
“ EBOV : Outbreaks, molecular epidemiology, immunity, persistence and surveillance ”
-
SIDACTION - Rencontre scientifique & solidaire
Pour renforcer la transversalité entre ses différents programmes et axes d’intervention et (...)
-
Soutenance de thèse de Pauline Bronnec, équipe I2BA (19.12.2025 à 14h00)
"Identification des variants pathogènes du gène MEFV"
-
Soutenance de thèse de Clara Vigneron, équipe NLR3P (18.12.2025 à 14h30)
Rôle de la voie de l'inflammasome dans l'expansion et les fonctions suppressives des plasmocytes (...)
